Compare JSPR & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JSPR | BGH |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.5M | 297.0M |
| IPO Year | N/A | N/A |
| Metric | JSPR | BGH |
|---|---|---|
| Price | $1.71 | $15.15 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $25.60 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 61.5K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.39 | $11.92 |
| 52 Week High | $23.11 | $14.50 |
| Indicator | JSPR | BGH |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 50.54 |
| Support Level | $1.61 | $14.99 |
| Resistance Level | $1.93 | $15.35 |
| Average True Range (ATR) | 0.21 | 0.14 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 31.07 | 44.64 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.